Kisqali (ribociclib) - Novartis
Ibrance (palbociclib) - Pfizer
Verzenio (abemaciclib) - Eli Lilly
https://www.sciencedirect.com/science/article/pii/S3051291326002855?via%3Dihub
 
F. Alorfi; Z. Haq; D. Priftakis; S. Voo; K. De Souza; Y. Mathur
 
Sep 29, 2026
 
Prev Next